Product Images Metoprolol Succinate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Metoprolol Succinate NDC 45963-676 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - image 1

1 - image 1

1 - image 10

1 - image 10

1 - image 11

1 - image 11

Metoprolol Succinate is a medicine that is available in the form of extended-release tablets. The tablets come in a pack of 100 and contain 25 mg of metoprololsuccinate, which is equivalent to 25 mg of metoprolol arirte. Each tablet is film-coated and should be dispensed in a tight, light-resistant container as defined in the USP. The usual dosage should be determined by consulting the accompanying literature for full prescribing information. The medication should be stored at 25° (77°F) with excursions permitted 015 10 30°C (59° 10 86°F) [see USP Controlled Room Temperature]. This medication should be kept out of the reach of children. Unfortunately, there is no information available in the text that can identify the medical purpose of this medication.*

1 - image 12

1 - image 12

NDC 45963-676-11 is a medication called Metoprolol Succinate that comes in the form of Extended-Release Tablets, USP with a strength of 50 mg. This particular package contains 100 tablets manufactured by TEVA. Each tablet contains 47.5 mg of metoprolol succinate, USP equivalent to 50 mg of metoprolol tartrate, USP. The medication should be kept in a tight, light-resistant container as defined by the USP and should be stored at room temperature between 59°F and 86°F. The usual dosage and prescribing information is available in the accompanying literature. This medication should be kept out of reach of children. LOTIEXP can be found below.*

1 - image 13

1 - image 13

Metoprolol Succinate Extended-Release Tablets, USP are a prescription medication that contains 95 mg of metoprolol succinate, USP which is equivalent to 100mg of metoprolol tartrate, USP. The medication is used to treat hypertension (high blood pressure) and angina pectoris (chest pain). The usual dosage should be determined by accompanying literature or a healthcare professional. The tablets are film-coated and are available as 100 tablets in each bottle. Store at controlled room temperature.*

1 - image 14

1 - image 14

Metoprolol Succinate is a medication available in the form of extended-release tablets, with a strength of 200 mg. The tablets contain 190 mg of Metoprolol Succinate, equivalent to 200 mg of metoprolol tartrate. The drug should be stored in a tightly closed, light-resistant container at 25°C. The usual dosage should be determined using the accompanying literature. This medication is manufactured by Teva Pharmaceuticals USA, Inc. and should be kept out of the reach of children. The given text seems to be a label or description of the drug.*

1 - image 2

1 - image 2

1 - image 3

1 - image 3

1 - image 4

1 - image 4

2 - image 5

2 - image 5

1 - image 6

1 - image 6

Results for Subgroups in MERIT-HF are not clearly available.*

1 - image 7

1 - image 7

1 - image 8

1 - image 8

1 - image 9

1 - image 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.